THE MEDICAL NEWS

A new test provides a much more complete picture of DNA than current standard diagnostics and leads to a diagnosis more often.

Researchers from Amsterdam UMC, in collaboration with other hospitals, have successfully completed the first-ever Phase 3 study of an in vivo CRISPR therapy.

A Southampton Solent University student is set to graduate with two jobs already secured, one with the Ambulance Service and one delivering trauma simulation training for the British military.

Women with HIV most often die from preventable, trauma-related conditions like substance use and mental illness - not the virus itself. Yet, these leading causes are largely missing from official death records, according to new research by UC San Francisco.

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions.

Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead the newly formed Houston Methodist Center for Cell and Gene Therapy.

The University of Oklahoma has received an $11.5 million award from the National Institutes of Health to establish the Oklahoma Center of ImmunoEngineering, a new research center designed to accelerate the study and treatment of diseases rooted in the immune system.